WRITTEN QUESTION E-5141/08 by Erik Meijer (GUE/NGL) , Jules Maaten (ALDE) , Bastiaan Belder (IND/DEM) , Paulo Casaca (PSE) and Feleknas Uca (GUE/NGL) to the Commission (24 September 2008) Subject: International recognition of the mass murder of Iraqi Kurds in the period 1987‑88 as genocide and contributing to medical support for the surviving victims 1. Is the Commission aware of the call by the regional government of Kurdistan in northern Iraq for international recognition of the nature of the Anfal campaign by the then Iraqi Government in the years 1987‑88 as a case of genocide? PM’s speech: ‘We call for international recognition of Anfal genocide’, http://www.krg.org/articles/detail.asp?lngnr=12&smap=02040100&rnr=268&anr=22516 2. Is the Commission familiar with the judgment by The Hague court in December 2005 against the poison gas dealer Frans van Anraat, in which the gas attacks on the Kurdish population in Iraq in the period 1987‑89 in connection with the Anfal operations are described as ‘genocide’? Judgment by The Hague court, case number 09/751003‑04. 3. Does the Commission agree with the regional government of Kurdistan and the Dutch court that this Anfal campaign may be judged to be genocide against the Kurds? If not, why not? 4. Does the Commission agree that an international inquiry should be held into the medical, social and economic consequences of the mass murder of the Kurds? What is the Commission doing to help set up that inquiry? Is the Commission prepared to work for this at international level? 5. Is the Commission aware that children are still being born with deformities that are attributable to the chemical attacks on the Kurdish towns and villages in Iraq by Saddam Hussein’s regime in 1988, and that in Iraqi Kurdistan an unusually large number of cases of cancer are occurring, including leukaemia, skin disease, eye disease and respiratory disorders, which are traceable to the poison gas attacks in 1988? 6. Is the Commission aware of the Halabja Post-Graduate Medical Institute (HMI) to Support Treatment, Research and Environmental Safety Programs for WMD Survivors? Information from Professor Christine Gosden of the University of Liverpool. Is the Commission aware that this programme has with relatively cheap resources, such as folic acid, obtained positive results in basic healthcare in Iraqi Kurdistan, but that the programme has been without financial resources since March 2006 even though its costs amount only to EUR 100 000 per year? 7. Does the Commission agree that, in view